Tue, 21-Oct-2025

Pfizer vaccine: No indications of possible signs shot stroke link found, says EU

Pfizer

The EU says the new Covid-19 injection has not been associated with any safety alerts in the region. Pfizer and BioNTech say they are aware of a small number of cases of ischemic strokes. The FDA and CDC have found no such indications of relation to stroke in other databases. The new Covid-19 injection from … Read more

New mRNA vaccine provides immunization to 20 known influenza A & B virus

influenza

Studies could pave the way for a universal flu shot that could help prevent future pandemics. Universal vaccination would eliminate the guesswork involved in designing annual vaccines months in advance of each flu season. Vaccine-induced antibody levels were stable for at least four months. In preliminary tests on mice and ferrets, an experimental vaccine provided … Read more

Moderna sues Pfizer and BioNTech for vaccine patent

Moderna

Moderna sued Pfizer and BioNTech in US federal court and in Germany on Friday, alleging they infringed on its messenger RNA patents for the COVID vaccines. Moderna accused the two firms of infringing on patents it filed between 2010 and 2016 by replicating its vaccination technology. Moderna CEO Stéphane Bancel claimed the company is suing … Read more

US approves to a $3.2 billion agreement for Pfizer’s Omicron

Pfizer's Omicron

US pfizer’s Omicron approves $3.2 billion deal to purchase 105 million doses of the BioNTech/Pfizer vaccine. The deal includes a planned new vaccine targeting the Omicron strain for the fall booster campaign.  An additional 195 million vaccines have not yet been approved by the FDA. Pfizer’s Omicron: The Biden Administration has approved a $3.2 billion … Read more

Pfizer Covid vaccine for under-fives effective with three doses

Pfizer

The Pfizer/BioNTech Covid vaccine is safe and effective for children aged six months to under five years when given in three doses, according to a statement released Monday by the companies. The announcement comes as the US Food and Drug Administration (FDA) plans meetings in the coming weeks to consider authorizing Covid vaccines for the … Read more

Existence vaccines are available both. yet, why are their stocks in free fall?

Existence vaccines

Pfizer, BioNTech and Moderna are experiencing a post-vaccine hangover on Wall Street this year. All 3 shares surged spectacularly in 2021, thanks in large part to their Covid-19 vaccines’ achievement and robust sales. But 2022 hasn’t been as kind to them. Shares of Pfizer (PFE) are down approximately 15%, whilst its Comirnaty vaccine partner BioNTech … Read more

Pfizer to seek US authorization for third Covid shot in children

Pfizer

Pfizer and BioNTech  announced positive from a scientific trial at the protection and immune reaction of a third dose of their Covid vaccine in kids elderly five through eleven, including they might soon seek regulatory authorization.on Thursday Third doses of the vaccine are endorsed for those aged 12 and up, and a fourth dose become … Read more

BioNTech profits soar in 2021 on global vaccine rollout

biontech

FRANKFURT: German vaccine-maker BioNTech on Wednesday reported a multi-billion-euro windfall in 2021 from sales of its anti-coronavirus jab, developed together with US pharmaceutical giant Pfizer. Mainz-based BioNTech said it made a net profit of 10.3 billion euros ($11.5 billion) last year, up from 15 million euros in 2020, the first year of the pandemic. The … Read more

S. Korea authorizes COVID-19 vaccine for children aged 5-11

south korea

SEOUL – South Korea’s drug safety agency on Wednesday authorized the use of COVID-19 vaccine for children aged 5-11 for the first time amid the rapid spread of the Omicron variant. The two-dose vaccine, developed by Pfizer and BioNTech, was approved for use among minors aged 5 through 11, with a lower dose level of … Read more

Pfizer seeks US approval of Covid vaccine for children under 5

pfizer

WASHINGTON: Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years. If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to this age group in … Read more

Pfizer-BioNTech begin Omicron vaccine trial: statement

Pfizer-BioNTech

WASHINGTON: Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday. Pfizer’s CEO Albert Bourla previously said at a conference that the pharmaceutical giant could be ready to file for … Read more

Pfizer and BioNTech to develop mRNA-based shingles jab

Pfizer

BERLIN, Jan 5, 2022 (AFP) – Germany’s BioNTech and US pharma giant Pfizer, which partnered up to develop a Covid-19 vaccine in record time, said Wednesday they are working on a shingles vaccine using the same breakthrough mRNA technology. The companies have signed a partnership deal and are aiming for clinical trials to start in the … Read more

Moderna says full booster dose improves Omicron protection

Omicron

PARIS, Dec 20, 2021 (AFP) – Giving a full dose of Moderna’s Covid-19 vaccine as a booster shot provides more antibody protection against the Omicron variant than currently authorised half-strength injections, the company said Monday. The lab study measured the levels of Omicron-neutralising antibodies in blood samples from 40 people who had low levels of these … Read more

Pfizer/BioNTech says three doses ‘effective’ against Omicron

Pfizer/BioNTech says three doses 'effective' against Omicron

FRANKFURT, Dec 8, 2021 (AFP) – The coronavirus vaccine developed jointly by BioNTech and Pfizer is “still effective” against the Omicron variant of the virus after three doses, the companies said in a statement on Wednesday. A laboratory study by its makers found the vaccine “is still effective in preventing Covid-19, also against Omicron, if it … Read more

World’s poorest countries deprived of COVID-19 vaccines: media

World's poorest countries deprived of COVID-19 vaccines: media

SINGAPORE: Pfizer, BioNTech and Moderna are making combined profits of 65,000 U.S. dollars every minute from their COVID-19 vaccines while the world’s poorest countries remain largely unvaccinated, local media cited AFP as reporting.

The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the People’s Vaccine Alliance (PVA), a coalition campaigning for wider access to COVID-19 vaccines, Singapore’s Chinese language newspaper Lianhe Zaobao reported.

The alliance estimates that the trio will make pre-tax profits of 34 billion dollars this year, which is equal to 65,000 dollars a minute.

“It is obscene that just a few companies are making millions of dollars in profit every single hour, while just 2 per cent of people in low-income countries have been fully vaccinated against the coronavirus,” the report quoted Maaza Seyoum of the African Alliance and People’s Vaccine Alliance Africa as saying.

Pfizer and BioNTech have delivered less than 1 percent of their total supplies to low-income countries while Moderna has delivered just 0.2 percent, the PVA said.

[embedpost slug=”beijing-administers-over-950000-covid-19-vaccine-doses-to-children/”]

Read more

Pfizer requests US emergency authorisation for Covid booster for adults

Pfizer, BioNtech Seek Permission To Administer Third Dose Of Vaccine

WASHINGTON: Drugmakers Pfizer and BioNTech announced on Tuesday they have formally submitted a request asking US officials for emergency authorisation of their Covid-19 booster vaccine for people aged 18 and older. The move follows research published by the companies in late October indicating a third shot is 95.6 per cent effective against symptomatic infection, based on clinical … Read more

Pfizer, BioNtech Seek Permission To Administer Third Dose Of Vaccine

Pfizer, BioNtech Seek Permission To Administer Third Dose Of Vaccine

The American pharmaceutical company Pfizer and the German biotechnology company BioNtech have announced that they are seeking approval from regulators for a third dose of the coronavirus vaccine. According to the reports, the company said in a statement that data from ongoing vaccine trials indicate that the initial type of virus and later beta variants … Read more

Oman Gives Approval For Emergency Use of Sputnik V And Sinovac

Oman Gives Approval For Emergency Use of Sputnik V And Sinovac

Oman grants emergency authorization for the use of Russia’s Sputnik V and China’s Sinovac vaccines, raising the total number of approved COVID-19 doses to four. The approval was granted as the sultanate is aiming to vaccinate all the target groups with one dose of vaccine by August. The Minister of Health Dr Ahmed Al Saeedi … Read more

Switzerland Announces Vaccination Of Age Group 12 to 15 Years

Switzerland Announces Vaccination Of Age Group 12 to 15 Years

Switzerland announces that children between 12 to 15 years old could be vaccinated with the shot from Pfizer and its German partner BioNTech. The recommendation was given earlier this month by the Swissmedic, drug regulator in Switzerland. It is mainly aimed at the youth in groups It is primarily directed at youth in groups who … Read more

Pfizer/BioNTech COVID-19 vaccine data under cyberattack

Pfizer/BioNTech

In a cyberattack on Europe’s medicines regulator, Pfizer and its German partner BioNTech said that documents related to coronavirus vaccine development on Wednesday had been “unlawfully accessed”.

The European Medicines Agency (EMA), which allows and approves medicines and vaccines for the Europen Union, said that it had been targeted in a cyberattack. It did not reveal any more details regarding the matter.

Moreover, Pfizer and BioNTech believed that no personal data of trial participants had been leaked and EMA “has assured us that the cyber attack will have no impact on the timeline for its review.”

It was not clear that when or how the EMA was attacked, or who was the culprit behind the cyberattack.

BioNTech spokeswoman had declined further comment and Pfizer also did not reply immediately to a request for more comment.

[embedpost slug=”how-will-pfizer-biontech-be-used-next-week/”]

Read more